FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897628033> ?p ?o ?g. }

• W2897628033 abstract "Fotemustine (FTM) is a treatment option in recurrent malignant gliomas (MGs) after first-line Stupp treatment. The efficacy and the safety of fractionated FTM schedule proposed by Addeo et al was analysed in the present study in recurrent MGs patients. A retrospective analysis on 40 recurrent MGs patients and second-line fractionated FTM chemotherapy was performed. Response evaluation was assessed using RANO criteria and safety was assessed using CTCAE v.4.03. Subgroup analyses based on MGMT methylation, resurgery and reirradiation were performed. A review of the literature was also performed. The results revealed 5 partial responses (13%) and 19 stable diseases (47%) with a disease-control rate of 60%. Median progression-free survival (PFS) was 4 months, with a PFS of 33% at 6 months and 13% at 1 year. The median overall survival (OS) was 9 months and OS at 6 months was of 55% and at 1 year of 30%. Methylated patients experienced longer mPFS (6 vs. 3 months; p=0.004) and mOS (10 vs. 4 months; p<0.0001) compared with unmethylated patients. Patients treated with reirradiation experienced longer mPFS (5 vs. 3.5 months; p=0.48) and mOS (10 vs. 5 months; p=0.11). No survival benefit with resurgery was observed. Furthermore, the fractioned schedule was well tolerated, only 15% of patients developed severe myelotoxicities. Considering the present findings, fractionated FTM schedule is an efficient second-line option for MGs associated with an acceptable myelotoxicity profile. Additionally, MGMT methylation is associated with improved survival outcomes. However, this study highlights the requirement for further prospective randomized studies on resurgery and reirradiation." @default.
• W2897628033 created "2018-10-26" @default.
• W2897628033 creator A5015546028 @default.
• W2897628033 creator A5039204628 @default.
• W2897628033 creator A5050343624 @default.
• W2897628033 creator A5058082424 @default.
• W2897628033 creator A5062044509 @default.
• W2897628033 creator A5064567867 @default.
• W2897628033 creator A5072550519 @default.
• W2897628033 creator A5076546888 @default.
• W2897628033 creator A5078881408 @default.
• W2897628033 date "2018-10-16" @default.
• W2897628033 modified "2023-10-18" @default.
• W2897628033 title "Non‑conventional fotemustine schedule as second‑line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature" @default.
• W2897628033 cites W1893588436 @default.
• W2897628033 cites W1974029597 @default.
• W2897628033 cites W1984681580 @default.
• W2897628033 cites W1991871891 @default.
• W2897628033 cites W1992708938 @default.
• W2897628033 cites W1997266665 @default.
• W2897628033 cites W2007208732 @default.
• W2897628033 cites W2046098727 @default.
• W2897628033 cites W2052491055 @default.
• W2897628033 cites W2054370305 @default.
• W2897628033 cites W2067260393 @default.
• W2897628033 cites W2092736872 @default.
• W2897628033 cites W2096287682 @default.
• W2897628033 cites W2104916880 @default.
• W2897628033 cites W2104958914 @default.
• W2897628033 cites W2105100844 @default.
• W2897628033 cites W2106939177 @default.
• W2897628033 cites W2112014411 @default.
• W2897628033 cites W2121396361 @default.
• W2897628033 cites W2132504500 @default.
• W2897628033 cites W2148977460 @default.
• W2897628033 cites W2154303411 @default.
• W2897628033 cites W2160382843 @default.
• W2897628033 cites W2162643152 @default.
• W2897628033 cites W2165772224 @default.
• W2897628033 cites W2234135665 @default.
• W2897628033 cites W2279568831 @default.
• W2897628033 cites W2302516330 @default.
• W2897628033 cites W2478972716 @default.
• W2897628033 cites W2557705601 @default.
• W2897628033 cites W2604913157 @default.
• W2897628033 doi "https://doi.org/10.3892/mco.2018.1746" @default.
• W2897628033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6313958" @default.
• W2897628033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30655978" @default.
• W2897628033 hasPublicationYear "2018" @default.
• W2897628033 type Work @default.
• W2897628033 sameAs 2897628033 @default.
• W2897628033 citedByCount "7" @default.
• W2897628033 countsByYear W28976280332019 @default.
• W2897628033 countsByYear W28976280332021 @default.
• W2897628033 countsByYear W28976280332022 @default.
• W2897628033 crossrefType "journal-article" @default.
• W2897628033 hasAuthorship W2897628033A5015546028 @default.
• W2897628033 hasAuthorship W2897628033A5039204628 @default.
• W2897628033 hasAuthorship W2897628033A5050343624 @default.
• W2897628033 hasAuthorship W2897628033A5058082424 @default.
• W2897628033 hasAuthorship W2897628033A5062044509 @default.
• W2897628033 hasAuthorship W2897628033A5064567867 @default.
• W2897628033 hasAuthorship W2897628033A5072550519 @default.
• W2897628033 hasAuthorship W2897628033A5076546888 @default.
• W2897628033 hasAuthorship W2897628033A5078881408 @default.
• W2897628033 hasBestOaLocation W28976280331 @default.
• W2897628033 hasConcept C126322002 @default.
• W2897628033 hasConcept C141071460 @default.
• W2897628033 hasConcept C143998085 @default.
• W2897628033 hasConcept C167135981 @default.
• W2897628033 hasConcept C187960798 @default.
• W2897628033 hasConcept C2776694085 @default.
• W2897628033 hasConcept C3019894029 @default.
• W2897628033 hasConcept C44249647 @default.
• W2897628033 hasConcept C71924100 @default.
• W2897628033 hasConceptScore W2897628033C126322002 @default.
• W2897628033 hasConceptScore W2897628033C141071460 @default.
• W2897628033 hasConceptScore W2897628033C143998085 @default.
• W2897628033 hasConceptScore W2897628033C167135981 @default.
• W2897628033 hasConceptScore W2897628033C187960798 @default.
• W2897628033 hasConceptScore W2897628033C2776694085 @default.
• W2897628033 hasConceptScore W2897628033C3019894029 @default.
• W2897628033 hasConceptScore W2897628033C44249647 @default.
• W2897628033 hasConceptScore W2897628033C71924100 @default.
• W2897628033 hasLocation W28976280331 @default.
• W2897628033 hasLocation W28976280332 @default.
• W2897628033 hasLocation W28976280333 @default.
• W2897628033 hasLocation W28976280334 @default.
• W2897628033 hasOpenAccess W2897628033 @default.
• W2897628033 hasPrimaryLocation W28976280331 @default.
• W2897628033 hasRelatedWork W1996136338 @default.
• W2897628033 hasRelatedWork W2039725704 @default.
• W2897628033 hasRelatedWork W2056829132 @default.
• W2897628033 hasRelatedWork W2276250243 @default.
• W2897628033 hasRelatedWork W2524976195 @default.
• W2897628033 hasRelatedWork W2561129920 @default.
• W2897628033 hasRelatedWork W2590324948 @default.
• W2897628033 hasRelatedWork W2900593311 @default.
• W2897628033 hasRelatedWork W3003132971 @default.
• W2897628033 hasRelatedWork W3139530928 @default.

• next